Hemostasis - About the company
Hemostasis is an unfunded company based in Saint Paul (United States), founded in 2006 by Keith Roberts. It operates as a Developer of a range of hemostats for bleeding control and wound control. Hemostasis has not raised any funding yet. The company has 163 active competitors, including 17 funded and 19 that have exited. Its top competitors include companies like Imbed Biosciences, NuVision and Alafair Biosciences.
Company Details
Developer of a range of hemostats for bleeding control and wound control. The products include BoneSeal absorbable, synthetic bone hemostat and promotes bone growth, NexStat plant-based polysaccharide for treating bleeding from Endoscopic Sinus Surgeries, NexStat Plus hemostat powder formulated with more hydrophilic particles that dehydrate blood cells, NexPak prevent adhesions in the nasal and sinus cavity, NexFoam plant-based polymer sponge for treating bleeding from Endoscopic Sinus Surgeries and other ENT procedures, PosiSep foam splints made from chitosan-based polymers to prevent adhesions and minimize bleeding in the nasal cavity, ExcelArrest to accelerate the clotting process to control bleeding from the skin, including vascular access and percutaneous catheter access sites, and BleedArrest foam sponges made from plant-based polymers for treating emergency epistaxis.
- Website
- www.hemostasisllc.com/
- Email ID
- *****@hemostasisllc.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2006
Location
Saint Paul, United States
Stage
Unfunded
Ranked
28th among 163 active competitors
Employee Count
46 as on Sep 30, 2026
Legal entities associated with Hemostasis
Hemostasis is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
HEMOSTASIS, LLC CIN: 4177917 , United States, Active | Jun 20, 2006 | - | - | - |
HEMOSTASIS, LLC CIN: 32084642084 , United States, Deadpooled | May 10, 2022 | - | - | - |
Sign up to download Hemostasis' company profile
Hemostasis's funding and investors
Hemostasis has not raised any funding rounds yet.
Hemostasis' founders and board of directors
Founder? Claim ProfileThe founders of Hemostasis is Keith Roberts. Keith Roberts is the CEO of Hemostasis.
Here are the details of Hemostasis' key team members:
- Keith Roberts: Co-Founder & CEO of Hemostasis. Contact Info: 1 email address
View details of Hemostasis's Founder profiles and Board Members
Hemostasis' employee count trend
Hemostasis has 46 employees as of Sep 26. Here is Hemostasis's employee count trend over the years:
Uncover Hemostasis' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Hemostasis's Competitors and alternates
Top competitors of Hemostasis include Imbed Biosciences, NuVision and Alafair Biosciences. Here is the list of Top 10 competitors of Hemostasis, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Imbed Biosciences 2010, Madison (United States), Series C | Provider of nanotech-based wound care products | $34.3M | 67/100 | |
2nd | NuVision 2015, Nottingham (United Kingdom), Public | Developer of an ophthalmic therapies for ocular surface disease | $13.4M | 59/100 | |
3rd | Alafair Biosciences 2011, Austin (United States), Series B | Biomaterials and biomedical devices that enhance internal wound healing | $13.7M | 58/100 | |
4th | Developer of advanced haemostat and wound care dressing products | $20.5M | 58/100 | ||
5th |  Kane Biotech 2001, Winnipeg (Canada), Public | Developer of therapeutic solutions to prevent and remove biofilms | - | 55/100 | |
6th | Cresilon 2010, New York City (United States), Series B | Developer of hemostatic products for wound care | $142M | 54/100 | |
7th |  Nanordica Medical 2019, Tallinn (Estonia), Seed | Provider of nanotech-based wound care products | $4.15M | 50/100 | |
8th | Lohmann & Rauscher 1998, Rengsdorf (Germany), Funding Raised | Dressing materials and medical devices | - | 50/100 | |
9th | Developer of hemostatic material and bone-subsitutes | - | 45/100 | ||
10th | MedTrade 1999, Crewe (United Kingdom), Series B | Portfolio of products for wound care and skin care | $30.4M | 43/100 | |
28th | Hemostasis 2006, Saint Paul (United States), Unfunded | Developer of a range of hemostats for bleeding control and wound control | - | - | 33/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Hemostasis's competitors? Click here to see the top ones
Hemostasis's Investments and acquisitions
Hemostasis has acquired 2 companies including Fiagon and Fiagon. Hemostasis has not made any investments as of now.Reports related to Hemostasis
Here is the latest report on Hemostasis's sector:
News related to Hemostasis
•
Teleflex Announces the Teleflex Center for Antimicrobial ProtectionGlobeNewswire•Jul 24, 2024•Teleflex Medical, Premier, Hemostasis
•
•
Terumo Cardiovascular Group and Hemostasis Introduce BoneSeal® Bone HemostatPR Newswire•Feb 19, 2019•https://terumo-cvgroup.com, Hemostasis
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Hemostasis
Explore our recently published companies
- Larkin Industries - Saint Paul based, 1976 founded, Funding Raised company
- Kirby Risk - Lafayette based, 1926 founded, Funding Raised company
- KIT - Les Sorinieres based, 2008 founded, Funding Raised company
- Kent Machine - United States based, 2002 founded, Unfunded company
- Kent Kraft - Kent based, 1994 founded, Unfunded company
- Kaizen Metal Forming - Noida based, 1993 founded, Unfunded company
